Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Malignant Female Reproductive System Neoplasm 2Rectal Neoplasms 1Pulmonary Nodule 1Pain, Postoperative 1Neoplasms 1Ileus 1Hematologic Neoplasms 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Cancer Pain 1Agnosia 1

Interventions

Meropenem 1Levofloxacin 1Hydromorphone 1Fentanyl 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Emergencies × Hydromorphone × Clear all
NCT01812759 2021-06-29

Fentanyl for Breakthrough Pain in the Emergency Department

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 8 charts

Emergencies, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡